X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5993) 5993
Book Review (1241) 1241
Publication (668) 668
Newsletter (184) 184
Newspaper Article (73) 73
Book Chapter (41) 41
Magazine Article (26) 26
Conference Proceeding (21) 21
Reference (15) 15
Book / eBook (9) 9
Dissertation (2) 2
Government Document (2) 2
Streaming Video (2) 2
Trade Publication Article (2) 2
Web Resource (2) 2
Presentation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4962) 4962
humans (4757) 4757
thalidomide (3612) 3612
male (2617) 2617
female (2417) 2417
hematology (2120) 2120
middle aged (2012) 2012
thalidomide - therapeutic use (1995) 1995
oncology (1941) 1941
aged (1844) 1844
thalidomide - analogs & derivatives (1843) 1843
multiple myeloma (1739) 1739
multiple myeloma - drug therapy (1600) 1600
adult (1408) 1408
thalidomide - administration & dosage (1352) 1352
treatment outcome (1271) 1271
lenalidomide (1156) 1156
bortezomib (1139) 1139
antineoplastic combined chemotherapy protocols - therapeutic use (1023) 1023
thalidomide - adverse effects (1013) 1013
therapy (987) 987
animals (896) 896
care and treatment (864) 864
thalidomide - pharmacology (803) 803
cancer (802) 802
dexamethasone (769) 769
antineoplastic agents - therapeutic use (753) 753
chemotherapy (742) 742
aged, 80 and over (729) 729
stem-cell transplantation (720) 720
abridged index medicus (609) 609
survival (609) 609
dexamethasone - administration & dosage (591) 591
multiple-myeloma (571) 571
drug therapy (570) 570
pharmacology & pharmacy (536) 536
research (526) 526
medicine & public health (525) 525
transplantation (525) 525
angiogenesis inhibitors - therapeutic use (509) 509
multiple myeloma - pathology (500) 500
multiple myeloma - therapy (495) 495
angiogenesis (492) 492
multiple myeloma - mortality (483) 483
prognosis (470) 470
mice (420) 420
disease-free survival (411) 411
health aspects (411) 411
analysis (410) 410
antineoplastic combined chemotherapy protocols - adverse effects (410) 410
recurrence (406) 406
immunology (372) 372
retrospective studies (349) 349
immunosuppressive agents - therapeutic use (348) 348
trial (346) 346
hematology, oncology and palliative medicine (345) 345
risk factors (329) 329
stem cells (329) 329
multiple myeloma - diagnosis (326) 326
follow-up studies (323) 323
expression (321) 321
survival analysis (320) 320
remission induction (314) 314
dose-response relationship, drug (313) 313
melphalan (306) 306
transplantation, autologous (306) 306
necrosis-factor-alpha (297) 297
plus dexamethasone (297) 297
combination (296) 296
article (295) 295
survival rate (295) 295
immunologic factors - therapeutic use (289) 289
dosage and administration (288) 288
drug therapy, combination (284) 284
boronic acids - administration & dosage (281) 281
pyrazines - administration & dosage (281) 281
antineoplastic agents - adverse effects (279) 279
disease progression (279) 279
myeloma (278) 278
cells (275) 275
clinical trials (275) 275
multiple myeloma - complications (272) 272
antineoplastic combined chemotherapy protocols - administration & dosage (270) 270
diagnosis (268) 268
clinical trials as topic (267) 267
prednisone (257) 257
combined modality therapy (250) 250
myelodysplastic syndromes - drug therapy (246) 246
dexamethasone - therapeutic use (244) 244
disease (244) 244
medicine, general & internal (244) 244
angiogenesis inhibitors (241) 241
boronic acids - therapeutic use (240) 240
pyrazines - therapeutic use (240) 240
stem cell transplantation (240) 240
elderly-patients (238) 238
antineoplastic agents - administration & dosage (237) 237
patients (236) 236
apoptosis (232) 232
aids/hiv (231) 231
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Robarts - Stacks (3) 3
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Music - Stacks (1) 1
Online Resources - Online (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6156) 6156
Japanese (46) 46
French (35) 35
Chinese (27) 27
German (27) 27
Spanish (17) 17
Czech (9) 9
Portuguese (8) 8
Polish (6) 6
Italian (5) 5
Russian (4) 4
Dutch (3) 3
Korean (3) 3
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 12, pp. 2039 - 2051
Abstract In contrast to the upfront setting in which the role of high-dose therapy with autologous hematopoietic cell transplantation (HCT) as consolidation of... 
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Myeloma | Salvage therapy | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | COMBINATION THERAPY | LENALIDOMIDE PLUS DEXAMETHASONE | AUTOLOGOUS TRANSPLANTATION | FOLLOW-UP | RISK | IMMUNOLOGY | TRANSPLANTATION | ALLOGENEIC TRANSPLANTATION | MAINTENANCE | RANDOMIZED PHASE-III | HEMATOLOGY | LOW-DOSE DEXAMETHASONE | Myeloablative Agonists - therapeutic use | Recurrence | Humans | Antibodies, Monoclonal - therapeutic use | Multiple Myeloma - immunology | Transplantation, Autologous | Bone Marrow Transplantation - methods | Remission Induction | Proteasome Inhibitors - therapeutic use | Transplantation, Homologous | Randomized Controlled Trials as Topic | Multiple Myeloma - pathology | Multiple Myeloma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Salvage Therapy - methods | Immunologic Factors - therapeutic use | Relapse | Multiple myeloma | Bone marrow | Clinical trials | Transplantation | Conferences and conventions | Hematopoietic stem cells | Trade and professional associations | Diseases | Index Medicus | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2017, Volume 177, Issue 3, pp. 457 - 466
Journal Article
Blood, ISSN 0006-4971, 03/2016, Volume 127, Issue 11, pp. 1481 - 1492
Current therapeutic strategies for sickle cell anemia are aimed at reactivating fetal hemoglobin. Pomalidomide, a third-generation immunomodulatory drug, was... 
GENE | BCL11A | INEFFECTIVE ERYTHROPOIESIS | IKAROS | HYDROXYUREA | ERYTHROID-CELLS | HEMOGLOBIN-SYNTHESIS | SICKLE-CELL-DISEASE | BETA-THALASSEMIA | HEMATOLOGY | EXPRESSION | Fetal Hemoglobin - biosynthesis | RNA, Small Interfering - genetics | Transcription, Genetic - drug effects | Erythroid Precursor Cells - drug effects | Humans | Erythropoiesis - drug effects | Thalidomide - pharmacology | Thalidomide - analogs & derivatives | RNA Interference | Gene Expression Regulation, Developmental | Adult | Kruppel-Like Transcription Factors - blood | Lentivirus - genetics | gamma-Globins - genetics | Neoplasm Proteins - genetics | beta-Globins - biosynthesis | Multiple Myeloma - blood | Hematopoietic Stem Cells - drug effects | Carrier Proteins - blood | Erythroid Precursor Cells - cytology | Nuclear Proteins - blood | Neoplasm Proteins - biosynthesis | Hematopoietic Stem Cells - metabolism | Ikaros Transcription Factor - drug effects | beta-Globins - genetics | Genetic Vectors - genetics | Histone Demethylases - blood | Ikaros Transcription Factor - blood | gamma-Globins - biosynthesis | Erythroid Precursor Cells - metabolism | Anemia, Sickle Cell - blood | Proteasome Endopeptidase Complex - metabolism | SOXD Transcription Factors - blood | Multiple Myeloma - genetics | Anemia, Sickle Cell - genetics | Index Medicus | Abridged Index Medicus | Red Cells, Iron, and Erythropoiesis
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 03/2018, Volume 12, Issue 3, pp. e0006214 - e0006214
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 20, pp. 2475 - 2482
Journal Article
Journal Article
Blood, ISSN 0006-4971, 08/2006, Volume 108, Issue 4, pp. 1158 - 1164
We present results of 2 similarly designed but separate phase 2 studies involving single-agent lenalidomide (CC-5013, Revlimid) in a total of 68 patients with... 
MULTIPLE-MYELOMA | GROWTH-FACTOR-BETA | LOW-DOSE THALIDOMIDE | CC-5013 | MYELOPROLIFERATIVE-DISORDERS | ANGIOGENESIS | ANALOGS | MUTATION | CELL TRANSPLANTATION | MYELODYSPLASTIC-SYNDROMES | HEMATOLOGY | Humans | Male | Primary Myelofibrosis - pathology | Neovascularization, Pathologic - complications | Primary Myelofibrosis - blood | Thrombocytopenia - genetics | Thalidomide - analogs & derivatives | Anemia - genetics | Anemia - drug therapy | Anemia, Myelophthisic - genetics | Time Factors | Splenomegaly - blood | Neutropenia - blood | Thalidomide - adverse effects | Primary Myelofibrosis - complications | Splenomegaly - genetics | Administration, Oral | Anemia, Myelophthisic - pathology | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Thrombocytopenia - pathology | Remission Induction | Neovascularization, Pathologic - drug therapy | Anemia, Myelophthisic - complications | Sequence Deletion | Splenomegaly - drug therapy | Anemia - blood | Anemia - pathology | Splenomegaly - pathology | Anemia, Myelophthisic - blood | Neovascularization, Pathologic - blood | Neovascularization, Pathologic - pathology | Janus Kinase 2 | Splenomegaly - complications | Protein-Tyrosine Kinases - genetics | Thrombocytopenia - drug therapy | Neutropenia - pathology | Adult | Female | Neutropenia - chemically induced | Neutropenia - genetics | Primary Myelofibrosis - drug therapy | Proto-Oncogene Proteins - genetics | Thrombocytopenia - blood | Anemia, Myelophthisic - drug therapy | Point Mutation | Anemia - complications | Primary Myelofibrosis - genetics | Platelet Count | Neovascularization, Pathologic - genetics | Aged | Hemoglobins - analysis | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 543 - 551
Summary Background Standard chemotherapy does not lead to long-term survival in patients with malignant pleural mesothelioma. Malignant pleural mesothelioma is... 
Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | MULTIPLE-MYELOMA | THERAPY | ONCOLOGY | PLEURAL-MESOTHELIOMA | VEGF | DOUBLE-BLIND | SERUM | II TRIAL | TUMOR ANGIOGENESIS | NONINVASIVE DIAGNOSIS | Lung Neoplasms - drug therapy | Multivariate Analysis | Mesothelioma - pathology | Guanine - analogs & derivatives | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Palliative Care | Cisplatin - administration & dosage | Pleural Neoplasms - drug therapy | Angiogenesis Inhibitors - administration & dosage | Time Factors | Female | Angiogenesis Inhibitors - adverse effects | Pleural Neoplasms - pathology | Lung Neoplasms - blood supply | Thalidomide - adverse effects | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Linear Models | Treatment Outcome | Thalidomide - administration & dosage | Chi-Square Distribution | Mesothelioma - blood supply | Pemetrexed | Pleural Neoplasms - blood supply | Disease Progression | Mesothelioma - drug therapy | Biomarkers, Tumor - blood | Mesothelioma - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Glutamates - administration & dosage | Pleural Neoplasms - blood | Aged | Lung Neoplasms - blood | Guanine - administration & dosage | Mesothelioma | Care and treatment | Chemotherapy | Thalidomide | Cancer | Index Medicus
Journal Article